Sawa Ito, Md

This study is testing a two-part treatment for people whose acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) has come back after a stem cell transplant. The treatment combines an immune-boosting drug (interferon-gamma) with an infusion of cells from the original tra…